Understanding variation in the results of real-world evidence studies that seem to address the same question
- 6 September 2022
- journal article
- research article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 151, 161-170
Abstract
No abstract availableKeywords
Funding Information
- Arnold Ventures
- National Institutes of Health (RO1HL141505)
- National Institute on Aging (R01AG053302)
This publication has 33 references indexed in Scilit:
- Risk of Bleeding With Dabigatran in Atrial FibrillationJAMA Internal Medicine, 2015
- Replication of the OMOP Experiment in Europe: Evaluating Methods for Risk Identification in Electronic Health Record DatabasesDrug Safety, 2013
- A general and simple method for obtaining R2 from generalized linear mixed‐effects modelsMethods in Ecology and Evolution, 2012
- Negative ControlsEpidemiology, 2010
- Orthogonal predictions: follow‐up questions for suggestive dataPharmacoepidemiology and Drug Safety, 2010
- Adjustments for Unmeasured Confounders in Pharmacoepidemiologic Database Studies Using External InformationMedical Care, 2007
- Statin Therapy and Risks for Death and Hospitalization in Chronic Heart FailureJAMA, 2006
- Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeuticsPharmacoepidemiology and Drug Safety, 2006
- Adjusting for Unmeasured Confounders in Pharmacoepidemiologic Claims Data Using External InformationEpidemiology, 2005
- Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older womenThe Lancet, 2000